Pharma-Bio Serv, Inc. financial data

Symbol
PBSV on OTC
Industry
Services-Management Consulting Services
Location
Industrial Zone Street 1, Lot 14, Dorado, Puerto Rico
Fiscal year end
October 31
Former names
LAWRENCE CONSULTING GROUP INC (to 2/28/2006)
Latest financial report
Q4 2023 - Mar 18, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 731 % -22.1%
Debt-to-equity 27.2 % +8.45%
Return On Equity 3.95 % -42.6%
Return On Assets 3.1 % -43.6%
Operating Margin 2.32 % -62.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23M shares -0.02%
Common Stock, Shares, Outstanding 23M shares +0.06%
Entity Public Float 13.6M USD +10.5%
Common Stock, Value, Issued 2.35K USD +0.26%
Weighted Average Number of Shares Outstanding, Basic 23M shares +0.08%
Weighted Average Number of Shares Outstanding, Diluted 23M shares +0.13%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 15.1M USD -18.8%
Cost of Revenue 10.8M USD -21.7%
Operating Income (Loss) 350K USD -69.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 855K USD -39.3%
Income Tax Expense (Benefit) 242K USD -13.5%
Net Income (Loss) Attributable to Parent 613K USD -45.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.87M USD -79.8%
Marketable Securities, Current 9.48M USD +14.9%
Accounts Receivable, after Allowance for Credit Loss, Current 2.41M USD -44.3%
Assets, Current 18.8M USD -7.22%
Property, Plant and Equipment, Net 26.4K USD -59.8%
Operating Lease, Right-of-Use Asset 318K USD -31.9%
Other Assets, Noncurrent 112K USD
Assets 19.2M USD -7.99%
Accounts Payable, Current 1.33M USD
Liabilities, Current 3.68M USD +87.5%
Accrued Income Taxes, Noncurrent 1.43M USD
Operating Lease, Liability, Noncurrent 154K USD -50.3%
Liabilities 5.07M USD +29.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 225K USD -1.95%
Retained Earnings (Accumulated Deficit) 12.9M USD -18.1%
Stockholders' Equity Attributable to Parent 14.2M USD -16.7%
Liabilities and Equity 19.2M USD -16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.74M USD -3.04%
Net Cash Provided by (Used in) Financing Activities -1.77M USD -0.82%
Net Cash Provided by (Used in) Investing Activities -778K USD +90.5%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 23.5M shares +0.24%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -812K USD +90%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.41M USD -11.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 347K USD -28.9%
Payments to Acquire Property, Plant, and Equipment 4 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 609K USD -50.9%
Lessee, Operating Lease, Liability, to be Paid 379K USD -31.6%
Property, Plant and Equipment, Gross 668K USD +1.07%
Operating Lease, Liability, Current 156K USD +8.25%
Lessee, Operating Lease, Liability, to be Paid, Year Two 175K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 175K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 32.1K USD -51.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 29.1K USD -83.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 175K USD 0%
Additional Paid in Capital 1.61M USD +2.88%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 54K USD -16.2%
Share-based Payment Arrangement, Expense 45.1K USD -37.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%